DOCSLIB.ORG

Chemotechnique Patch Test Products & Reference Manual

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Patch Test Products & Reference Manual 2018 7 Patch Test Products & Reference Manual 2018 DISTRIBUTOR MB Diagnostics AB Chemotechnique ©2017 Chemotechnique MB Diagnostics AB ©2017 Chemotechnique MB Diagnostics rev 20171128 Chemotechnique MB Diagnostics AB Modemgatan 9 | SE-235 39 | Vellinge | Sweden Tel +46 40 466 077 | www.chemotechnique.se President’s message With 2017 coming to an end, I look back at the past year with a sense of fulfillment. I reflect on the challenges overcome, the accomplishments achieved and the advancements made in the field of contact allergy. Entering 2018, our full hapten range is registered as pharmaceuticals in Canada following a lengthy regulatory process. The approved registration, the first in history, is a testament to the superior quality of the Chemotechnique products. This accomplishment has been achieved through the tireless work performed by our laboratory staff and from our North American distributor Dormer Laboratories and their consultants. I take this opportunity to extend my appreciation not only to the people involved but to all people fighting to overcome varying regulatory hurdles that are being imposed onto Patch Testing around the world, thereby limiting its beneficial expansion. The notion that an increasing number of patients previously undiagnosed are now experiencing an enhanced quality of life through the diagnosis of contact allergy assures me that Patch Testing remains as relevant as ever before, and I am of the firm belief that Patch Testing is, and will continue to be, a procedure worth fighting for. Always at your service, Bo Niklasson CEO and President Chemotechnique MB Diagnostics AB 1 The Chemotechnique crew at the ESCD in Manchester 2016 Patch Test Products authorized by the ICDRG Distributed Worldwide Production: Chemotechnique MB Diagnostics AB Printing: Exakta 2017 Revised: November 2017 © 2017 Chemotechnique MB Diagnostics AB Chemotechnique MB Diagnostics AB Modemgatan 9 | SE-235 39 | Vellinge Sweden | Tel +46 40 466 077 www.chemotechnique.se 2 Table of Contents Table of Contents President’s message ......................................................................1 Chemotechnique ............................................................................4 Contact Allergy ..............................................................................6 Patch Test Products .......................................................................8 • IQ Ultra™ ..........................................................................10 • IQ Ultimate™ ................................................................... .11 • Patch Test Accessories ...................................................12 • Spot Tests .........................................................................13 • Patch Test Haptens ..........................................................14 • Hapten Series ............................................................16 • International Baseline Series ............................17 • International Screening Series ..........................17 Patch Test Instructions ................................................................21 Featured topics .............................................................................24 Clinical information ......................................................................26 FAQ ................................................................................................32 Compostion of International Baseline Series ..............................33 Compostion of International Screening Series .........................53 List of Haptens ..............................................................................78 Hapten Information .....................................................................103 Catalogue amendments .............................................................210 • Catalogue amendments January 2018 .........................213 3 Chemotechnique the Trusted name in Patch Testing Chemotechnique - The trusted name in Patch Testing Chemotechnique MB Diagnostic AB (“Chemotechnique”) has provided Patch Test solutions since 1981 and is proudly recognized as the Trusted name in Patch Testing. Chemotechnique is a Sweden based company with global reach through world-wide distribution. Research and Development With emphasis on R&D and working in close cooperation with contact dermatitis research groups such as the International Contact Dermatitis Research Group (ICDRG), the European Environmental and Contact Dermatitis Research Group (EECDRG) and the North American Contact Dermatitis Group (NACDG), Chemotechnique ensures an ideally composed product line-up. Highest quality products Chemotechnique offers a complete range of high quality Patch Test Products including Patch Test Haptens, Patch Test Units as well as Patch Test Accessories and Spot Tests. Our haptens are produced in Sweden under strict pharmaceutical control following the GMP quality management system audited by the Swedish Medical Products Agency. Certified by the ISO 13485 and ISO 9001 Quality Management systems the Chemotechnique high quality products and reliable service will aid you in the diagnosis of contact allergy in your patients. Online resources Visit the continually updated www.chemotechnique.se website to access the Chemotechnique online resources including an extensive Hapten Database, patch testing Video Instructions, Patch test record forms, Patient information sheets and much more. Create a free account today! 4 the Trusted name in Patch Testing Countries (in blue) in which Chemotechnique offers local distribution www.chemotechnique.se for both desktop and mobile 5 Contact Allergy 1 out of 10 is sensitized to nickel Contact Allergy & Allergic Contact Dermatitis (ACD) Contact Allergy is the result of specific immune responses caused by antigens. Unlike allergens (such as pollens and animal proteins) causing other forms of allergy, the culprits of Contact Allergies, haptens, are not antigens by themselves. Haptens (typically small, chemically reactive molecules with low molecular weight) need to penetrate the horny layer of the skin in order to conjugate to epidermal and dermal proteins forming “hapten-carrier complexes” with antigenic properties capable of causing contact allergy. Examples of widely recognized haptens include nickel, formaldehyde and other preservatives in cosmetics. Allergen Contact allergy is the state of being sensitized to a hapten. Sensitization to Stratum a hapten occurs when the accumulated corneum exposure to the hapten surpasses a Hapten certain threshold. This threshold is individual and varies greatly, some will develop an allergy the first time encountering the hapten while others withstand a life time of exposure without becoming sensitized. The median prevalence of contact allergy to at least one hapten is around 25% in the general population. Allergic Contact Dermatitis (ACD) is a disease of the skin that can emerge in people that are exposed to specific haptens after having developed contact allergy to them. Once allergic, the subject might respond with skin inflammation (redness, flaking skin or blisters) whenever exposed. Individuals handling haptens as part of their 6 Contact Allergy Introduction profession run a higher risk of developing ACD. ACD accounts for 20% of all reported work related skin diseases. Occupational fields with high occurrences of ACD include (but are not limited to) hairdressing, construction work, cleaning and health care. Chronic once developed, and with no known cure, contact allergy is of major distress for those affected. Diagnosis While contact allergy cannot be treated it can be diagnosed; by Patch Testing and not by Skin Allergy Testing (such as skin prick testing - used for the diagnosis of, for instance, respiratory allergies). Knowing what hapten is causing the allergic reactions helps the patient stay clear of that specific hapten, avoiding ACD and thereby effectively improving the quality of life for the individual. The indication for Patch Testing is to test all patients in whom contact allergy is suspected or needs to be ruled out, regardless of age or anatomical site of dermatitis. Chemotechnique provides all tools required to perform patch tests the IQ way - the gold standard for diagnosing contact allergy. In order to perform a diagnostic Patch Test, two crucial components are required; Patch Test Haptens and Patch Test Units. Patch Test Haptens The hapten preparations used in patch testing should ideally be specifically developed for patch testing purposes. The Patch Test Haptens manufactured by Chemotechnique are standardized and prepared by mixing high purity fine particle ground raw material with high purity grade white petrolatum using state of the art technology. Patch Test Units To ensure that the hapten remains in direct contact with the skin for the time required (48h) to create a standardized controlled reaction, a Patch Test Unit is needed. A Patch Test Unit is composed of sets of chambers mounted on an adhesive tape. The purpose of the patch test chambers is to provide a defined areai in which the skin will be exposed to the haptens during the testing. 7 Patch Test Products IQ Chamber with hapten IQ Patch Test Chambers The Inert Quadrate (IQ) chambers are the most technologically advanced patch test chambers ever developed. The laminated tape/foam/filter paper construction results in a comfortable chamber providing a unique closed-cell and leak-free system which defines a test area. The quadrate shape allows
Recommended publications
  • Research Article Development and Validation of a Stability Indicating

    Research Article Development and Validation of a Stability Indicating

    Hindawi Publishing Corporation ISRN Chromatography Volume 2013, Article ID 506923, 12 pages http://dx.doi.org/10.1155/2013/506923 Research Article Development and Validation of a Stability Indicating RP-HPLC Method for the Determination of Two Sun Protection Factors (Koptrizon and Tinosorb S) in Topical Pharmaceutical Formulations Using Experimental Designs Chinmoy Roy1,2 and Jitamanyu Chakrabarty2 1 Analytical Research and Development, Dr. Reddy’s Laboratories Ltd., Bachupally, Hyderabad, Andhra Pradesh 500090, India 2 Department of Chemistry, National Institute of Technology, Durgapur, West Bengal 713209, India Correspondence should be addressed to Chinmoy Roy; [email protected] Received 11 March 2013; Accepted 15 April 2013 Academic Editors: C. Akbay and J. A. P. Coelho Copyright © 2013 C. Roy and J. Chakrabarty. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. A novel, simple, validated stability indicating HPLC method was developed for determination of Koptrizon and Tinosorb S. Stability indicating power of the method was established by forced degradation study. The chromatographic separation was achieved with Waters X Bridge C18 column, by using mobile phase consisting of a mixture of acetonitrile : tetrahydrofuran : water (38 : 38 : 24, v/v/v). The method fulfilled validation criteria and was shown to be sensitive, with limits of detection (LOD) and quantitation −1 −1 (LOQ) of 0.024 and 0.08 gmL for Koptrizon and 0.048 and 0.16 gmL for Tinosorb S, respectively. The developed method is validated for parameters like precision, accuracy, linearity, solution stability, specificity, and ruggedness as per ICH norms.
  • Tackling Fuel Laundering

    Tackling Fuel Laundering

    12 Tackling Fuel Laundering 12.1 In 2015, €2.6 billion was collected by the Revenue Commissioners (Revenue) in excise duty on mineral oils in the form of mineral oil tax and carbon tax. This represents almost half (47%) of the total excise duty of €5.5 billion collected by Revenue in that year. 12.2 All taxes are subject to risk of fraud and evasion. In the case of mineral oils, fuel ‘launderers’ use techniques to remove markers from the fuel making the use of sight tests ineffective for detecting the illegal use of fuel. By removing the marker, fuel that is subject to a lower rate of excise duty and VAT can be sold on as fuel with a higher sale price. 12.3 Revenue has introduced a number of initiatives as part of a Mineral Oils Strategy implemented in 2011 to combat the illicit fuel market and fuel laundering in Ireland. 12.4 This report examines . the actions taken by Revenue in recent years to tackle the issue of fuel laundering . the cost to the State in taxes forgone as a result of fuel laundering. Excise duty 12.5 There are three categories of excisable products - mineral oils, alcohol and alcoholic beverages, and manufactured tobacco products. Excise duties are also chargeable on certain premises or activities (for example, betting and licences for retailing of liquor).1 Figure 12.1 shows the excise receipts related to mineral oils as a proportion of the total excise duty collected for the period 2010 to 2015. Annex A provides a detailed breakdown of the excise duty collected between 2010 and 2015.
  • Effect of 10 UV Filters on the Brine Shrimp Artemia Salina and the Marine Microalgae Tetraselmis Sp

    Effect of 10 UV Filters on the Brine Shrimp Artemia Salina and the Marine Microalgae Tetraselmis Sp

    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.30.926451; this version posted January 31, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Effect of 10 UV filters on the brine shrimp Artemia salina and the marine microalgae Tetraselmis sp. Evane Thorel, Fanny Clergeaud, Lucie Jaugeon, Alice M. S. Rodrigues, Julie Lucas, Didier Stien, Philippe Lebaron* Sorbonne Université, CNRS USR3579, Laboratoire de Biodiversité et Biotechnologie Microbienne, LBBM, Observatoire Océanologique, 66650, Banyuls-sur-mer, France. *corresponding author : E-mail address : [email protected] Abstract The presence of pharmaceutical and personal care products’ (PPCPs) residues in the aquatic environment is an emerging issue due to their uncontrolled release, through grey water, and accumulation in the environment that may affect living organisms, ecosystems and public health. The aim of this study is to assess the toxicity of benzophenone-3 (BP-3), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), butyl methoxydibenzoylmethane (BM), methylene bis- benzotriazolyl tetramethylbutylphenol (MBBT), 2-Ethylhexyl salicylate (ES), diethylaminohydroxybenzoyl hexyl benzoate (DHHB), diethylhexyl butamido triazone (DBT), ethylhexyl triazone (ET), homosalate (HS), and octocrylene (OC) to marine organisms from two major trophic levels including autotrophs (Tetraselmis sp.) and heterotrophs (Artemia salina). In general, EC50 results show that both HS and OC are the most toxic for our tested species, followed by a significant effect of BM on Artemia salina but only at high concentrations (1 mg/L) and then an effect of ES, BP3 and DHHB on the metabolic activity of the microalgae at 100 µg/L.
  • Steroid Use in Prednisone Allergy Abby Shuck, Pharmd Candidate

    Steroid Use in Prednisone Allergy Abby Shuck, Pharmd Candidate

    Steroid Use in Prednisone Allergy Abby Shuck, PharmD candidate 2015 University of Findlay If a patient has an allergy to prednisone and methylprednisolone, what (if any) other corticosteroid can the patient use to avoid an allergic reaction? Corticosteroids very rarely cause allergic reactions in patients that receive them. Since corticosteroids are typically used to treat severe allergic reactions and anaphylaxis, it seems unlikely that these drugs could actually induce an allergic reaction of their own. However, between 0.5-5% of people have reported any sort of reaction to a corticosteroid that they have received.1 Corticosteroids can cause anything from minor skin irritations to full blown anaphylactic shock. Worsening of allergic symptoms during corticosteroid treatment may not always mean that the patient has failed treatment, although it may appear to be so.2,3 There are essentially four classes of corticosteroids: Class A, hydrocortisone-type, Class B, triamcinolone acetonide type, Class C, betamethasone type, and Class D, hydrocortisone-17-butyrate and clobetasone-17-butyrate type. Major* corticosteroids in Class A include cortisone, hydrocortisone, methylprednisolone, prednisolone, and prednisone. Major* corticosteroids in Class B include budesonide, fluocinolone, and triamcinolone. Major* corticosteroids in Class C include beclomethasone and dexamethasone. Finally, major* corticosteroids in Class D include betamethasone, fluticasone, and mometasone.4,5 Class D was later subdivided into Class D1 and D2 depending on the presence or 5,6 absence of a C16 methyl substitution and/or halogenation on C9 of the steroid B-ring. It is often hard to determine what exactly a patient is allergic to if they experience a reaction to a corticosteroid.
  • Chemical UVR Absorbers

    Chemical UVR Absorbers

    Chemical UVR Absorbers The names given in bold and used Diisopropyl methyl cinnamate Glyceryl ethyihexanoate dimethoxy- throughout this handbook are those of Empirical formula: cinnamate the International Nomenclature of C 6H22O2 Chemical names. Cosmetic Ingredients. Glyceryl octanoate dimethoxycinnamate; Chemical names: 2-propenoic acid, 3-(4-methoxyphenyl)-, 2-Propenoic acid, 3-12,4bis(1 diester with 1 ,3-dihydroxy-2-(2-ethyl-1 - methylethyphenyl-methyl ester; 2,5- oxohexyl)oxypropane diisopropyl methyl cinnamate _ lsoamyl-para-methoxycinnamate Ethyihexyl methoxycinnamate Empirical formula: Empirical formula: C151-12003 C 8H26O3 Chemical names: Cinnamates Chemical names: Amyl4-methoxycinnamate; isopentyl-4- 2-Ethylhexyl-4-methoxycin nam ate; methoxycinnamate; isopenlyl-para- Cinoxate 2-ethyl-hexyl-para-methoxycinnamate; methoxy-cinnamate; 3-(4-methoxyphenyl)- Empirical formula: para-methoxycinnamic acid, 2-ethylhexyl 2-propenoic acid, isopentyl ester Ci4HieO4 ester; 3-(4-methoxyphenyl)-2-propenoic acid, 2-ethylhexyl ester; octinoxate; octyl Trade names: Chemical names: methoxycinnamate; 2-propenoic acid, 3- Neo Heliopan type E 1000; Solarum AMC 2- Ethoxyothyl-para-methoxyci n nam ate; (4-methoxyphenyl)-2-ethylhexyl ester 2-propenoic acid, 3-(4-methoxyphery- para-A minobenzoic acids (PA BAs) 2-ethoxyethyl ester; 2-ethoxyethyl-4- Trade names: methoxycinnamate AEC Octyl Methoxycinnamate; Escalol Amyl dimethyl FABA 557; Eusolex 2292; Heliosol 3; Empirical formula: Trade names: Jeescreen OMC; Katoscreen OMC; Nec C14H21 NO2 Giv Tan F; Phiasol
  • WO 2013/036901 A2 14 March 2013 (14.03.2013) P O P C T

    WO 2013/036901 A2 14 March 2013 (14.03.2013) P O P C T

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/036901 A2 14 March 2013 (14.03.2013) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 8/30 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/US2012/054376 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 10 September 2012 (10.09.2012) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (26) Publication Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (30) Priority Data: ZM, ZW. 61/532,701 9 September 201 1 (09.09.201 1) US (84) Designated States (unless otherwise indicated, for every (71) Applicant (for all designated States except US): UNIVER¬ kind of regional protection available): ARIPO (BW, GH, SITY OF FLORIDA RESEARCH FOUNDATION, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, INC.
  • Annex VI, Last Update: 02/08/2021

    Annex VI, Last Update: 02/08/2021

    File creation date: 03/10/2021 Annex VI, Last update: 22/09/2021 LIST OF UV FILTERS ALLOWED IN COSMETIC PRODUCTS Substance identification Conditions Wording of Reference Maximum conditions of Product Type, concentration Update date number Chemical name / INN / XAN Name of Common Ingredients Glossary CAS Number EC Number Other use and body parts in ready for use warnings preparation 2 N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl CAMPHOR BENZALKONIUM 52793-97-2 258-190-8 6% 15/10/2010 ) anilinium methyl sulphate METHOSULFATE 3 Benzoic acid, 2-hydroxy-, HOMOSALATE 118-56-9 204-260-8 10% 02/08/2021 3,3,5-trimethylcyclohexyl ester / Homosalate 4 2-Hydroxy-4-methoxybenzophenone / BENZOPHENONE-3 131-57-7 205-031-5 6% Reg (EU) Not more than Contains 02/08/2021 Oxybenzone 2017/238 of 10 0,5 % to protect Benzophenone-3 February 2017- product (1) date of formulation application from September 2017 6 2-Phenylbenzimidazole-5-sulphonic acid and its PHENYLBENZIMIDAZOLE SULFONIC 27503-81-7 248-502-0 8%(as acid) 08/03/2011 potassium, sodium and triethanolamine salts / ACID Ensulizole 7 3,3'-(1,4-Phenylenedimethylene) bis TEREPHTHALYLIDENE DICAMPHOR 92761-26-7 / 410-960-6 / - 10%(as acid) 26/10/2010 (7,7-dimethyl-2-oxobicyclo-[2.2.1] SULFONIC ACID 90457-82-2 hept-1-ylmethanesulfonic acid) and its salts / Ecamsule 8 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl) BUTYL 70356-09-1 274-581-6 5% 15/10/2010 propane-1,3-dione / Avobenzone METHOXYDIBENZOYLMETHANE 9 alpha-(2-Oxoborn-3-ylidene)toluene-4-sulphoni BENZYLIDENE CAMPHOR SULFONIC 56039-58-8 - 6%(as acid)
  • Contact Dermatitis to Medications and Skin Products

    Contact Dermatitis to Medications and Skin Products

    Clinical Reviews in Allergy & Immunology (2019) 56:41–59 https://doi.org/10.1007/s12016-018-8705-0 Contact Dermatitis to Medications and Skin Products Henry L. Nguyen1 & James A. Yiannias2 Published online: 25 August 2018 # Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract Consumer products and topical medications today contain many allergens that can cause a reaction on the skin known as allergic contact dermatitis. This review looks at various allergens in these products and reports current allergic contact dermatitis incidence and trends in North America, Europe, and Asia. First, medication contact allergy to corticosteroids will be discussed along with its five structural classes (A, B, C, D1, D2) and their steroid test compounds (tixocortol-21-pivalate, triamcinolone acetonide, budesonide, clobetasol-17-propionate, hydrocortisone-17-butyrate). Cross-reactivities between the steroid classes will also be examined. Next, estrogen and testosterone transdermal therapeutic systems, local anesthetic (benzocaine, lidocaine, pramoxine, dyclonine) antihistamines (piperazine, ethanolamine, propylamine, phenothiazine, piperidine, and pyrrolidine), top- ical antibiotics (neomycin, spectinomycin, bacitracin, mupirocin), and sunscreen are evaluated for their potential to cause contact dermatitis and cross-reactivities. Finally, we examine the ingredients in the excipients of these products, such as the formaldehyde releasers (quaternium-15, 2-bromo-2-nitropropane-1,3 diol, diazolidinyl urea, imidazolidinyl urea, DMDM hydantoin), the non- formaldehyde releasers (isothiazolinones, parabens, methyldibromo glutaronitrile, iodopropynyl butylcarbamate, and thimero- sal), fragrance mixes, and Myroxylon pereirae (Balsam of Peru) for contact allergy incidence and prevalence. Furthermore, strategies, recommendations, and two online tools (SkinSAFE and the Contact Allergen Management Program) on how to avoid these allergens in commercial skin care products will be discussed at the end.
  • Experimental Study of the Bio-Additives in Biodiesel Fuel on Performance and Emissions Characteristics of Diesel Engine

    Experimental Study of the Bio-Additives in Biodiesel Fuel on Performance and Emissions Characteristics of Diesel Engine

    EXPERIMENTAL STUDY OF THE BIO-ADDITIVES IN BIODIESEL FUEL ON PERFORMANCE AND EMISSIONS CHARACTERISTICS OF DIESEL ENGINE. SYAHRUNNIZA BIN ABD HADI A project report submitted in partial fulfilment of the requirements for the award of Master Degree of Mechanical Engineering with Honors Faculty of Mechanical and Manufacturing Engineering Universiti Tun Hussein Onn Malaysia JULY 2015 v ABSTRACT Among the alternative fuels the Bio diesel is one the most common and familiar to all. It’s biodegradable, environment friendly as well as suitable source, to meet the future energy crises. The main concern of this experimental analysis is to reach a tentative goal, how this fuel can be utilised with maximum effective way. To find this ,an experiment data analysis of different parameter such as break power, break mean effective pressure consumption, emission characteristic (NOx, HC,CO. etc.), is done through bio diesel fuel and also compared with ordinary diesel which is also known as standard diesel. Despite years of improvement attempts, the key issue in using bio based fuels is oxidation stability, stoichiometric point, bio-fuel composition, antioxidants on the degradation and much oxygen with comparing to diesel gas oil. Thus, the improvement of emission exhausted from diesel engines fuelled by biodiesel is urgently required to meet the future stringent emission regulations. This investigation is carried out through 20 HP eddy current dynamometer and load cell arrangement which is controlled by a DYNOMAXtm software computer in case of finding the break power and BMEP respectively. And the emission characteristics are observed using Airrex HG-540 exhaust analysers finally the result is compared with diesel engine which is run by standard diesel.
  • Part I. the Effect of Ultraviolet Light Upon Some Organic Compounds, Part II. the Synthesis of Amino Compounds Lloyd L

    Part I. the Effect of Ultraviolet Light Upon Some Organic Compounds, Part II. the Synthesis of Amino Compounds Lloyd L

    Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 1930 Part I. The effect of ultraviolet light upon some organic compounds, Part II. The synthesis of amino compounds Lloyd L. Heck Iowa State College Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Organic Chemistry Commons Recommended Citation Heck, Lloyd L., "Part I. The effect of ultraviolet light upon some organic compounds, Part II. The synthesis of amino compounds" (1930). Retrospective Theses and Dissertations. 14760. https://lib.dr.iastate.edu/rtd/14760 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. INFORWIATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bieedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion.
  • Rectal Corticosteroids Versus Alternative Treatments in Ulcerative Colitis: a Meta-Analysis Gut: First Published As 10.1136/Gut.40.6.775 on 1 June 1997

    Rectal Corticosteroids Versus Alternative Treatments in Ulcerative Colitis: a Meta-Analysis Gut: First Published As 10.1136/Gut.40.6.775 on 1 June 1997

    Gut 1997; 40: 775-781 775 Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis Gut: first published as 10.1136/gut.40.6.775 on 1 June 1997. Downloaded from J K Marshall, E J Irvine Abstract medication consistently to the splenic Background-Clear strategies to optimise flexure,49 and a larger volume seems to allow the use of corticosteroids in ulcerative more proximal delivery.10 11 Rectal foam dis- colitis are lacking. seminates medication to the rectum and distal Aim-A meta-analysis was undertaken to descending colon,'2-16 whereas suppositories examine critically the role of rectal corti- coat only the rectum.'7 18 costeroids in the management of active Although studies of rectally administered distal ulcerative colitis. corticosteroids have reported fewer systemic Methods-AJl reported randomised con- adverse effects than with oral preparations, trolled trials were retrieved by searching plasma concentrations of prednisolone were the Medline and EMBASE databases and similar after administration of identical oral or the bibliographies of relevant studies. rectal doses.'9 20 Suppression of the hypo- Trials which met inclusion criteria were thalamic-pituitary-adrenal axis in association assessed for scientific rigour. Data were with rectal therapy has also been shown.2' 26 extracted by two independent observers Newer topically active corticosteroids such according to predetermined criteria. as tixocortol, beclomethasone, prednisolone Results-Of 83 trials retrieved, 33 met metasulphabenzoate, and budesonide, with inclusion criteria. Pooled odds ratios restricted absorption or rapid hepatic metab- (POR) showed conventional rectal corti- olism have been developed to reduce the costeroids and rectal budesonide to be adverse effects associated with conventional clearly superior to placebo.
  • Vr Meds Ex01 3B 0825S Coding Manual Supplement Page 1

    Vr Meds Ex01 3B 0825S Coding Manual Supplement Page 1

    vr_meds_ex01_3b_0825s Coding Manual Supplement MEDNAME OTHER_CODE ATC_CODE SYSTEM THER_GP PHRM_GP CHEM_GP SODIUM FLUORIDE A12CD01 A01AA01 A A01 A01A A01AA SODIUM MONOFLUOROPHOSPHATE A12CD02 A01AA02 A A01 A01A A01AA HYDROGEN PEROXIDE D08AX01 A01AB02 A A01 A01A A01AB HYDROGEN PEROXIDE S02AA06 A01AB02 A A01 A01A A01AB CHLORHEXIDINE B05CA02 A01AB03 A A01 A01A A01AB CHLORHEXIDINE D08AC02 A01AB03 A A01 A01A A01AB CHLORHEXIDINE D09AA12 A01AB03 A A01 A01A A01AB CHLORHEXIDINE R02AA05 A01AB03 A A01 A01A A01AB CHLORHEXIDINE S01AX09 A01AB03 A A01 A01A A01AB CHLORHEXIDINE S02AA09 A01AB03 A A01 A01A A01AB CHLORHEXIDINE S03AA04 A01AB03 A A01 A01A A01AB AMPHOTERICIN B A07AA07 A01AB04 A A01 A01A A01AB AMPHOTERICIN B G01AA03 A01AB04 A A01 A01A A01AB AMPHOTERICIN B J02AA01 A01AB04 A A01 A01A A01AB POLYNOXYLIN D01AE05 A01AB05 A A01 A01A A01AB OXYQUINOLINE D08AH03 A01AB07 A A01 A01A A01AB OXYQUINOLINE G01AC30 A01AB07 A A01 A01A A01AB OXYQUINOLINE R02AA14 A01AB07 A A01 A01A A01AB NEOMYCIN A07AA01 A01AB08 A A01 A01A A01AB NEOMYCIN B05CA09 A01AB08 A A01 A01A A01AB NEOMYCIN D06AX04 A01AB08 A A01 A01A A01AB NEOMYCIN J01GB05 A01AB08 A A01 A01A A01AB NEOMYCIN R02AB01 A01AB08 A A01 A01A A01AB NEOMYCIN S01AA03 A01AB08 A A01 A01A A01AB NEOMYCIN S02AA07 A01AB08 A A01 A01A A01AB NEOMYCIN S03AA01 A01AB08 A A01 A01A A01AB MICONAZOLE A07AC01 A01AB09 A A01 A01A A01AB MICONAZOLE D01AC02 A01AB09 A A01 A01A A01AB MICONAZOLE G01AF04 A01AB09 A A01 A01A A01AB MICONAZOLE J02AB01 A01AB09 A A01 A01A A01AB MICONAZOLE S02AA13 A01AB09 A A01 A01A A01AB NATAMYCIN A07AA03 A01AB10 A A01